Generex Announces ASCO Presentations of AE37 Vaccine Data

barbara.lempert Generex Announces ASCO Presentations of AE37 Vaccine Data; Potential Leading Immunotherapy Option for Breast Cancer Patients Treatment Regimen Targets All HER2 Expressing ...

Royalty Pharma Statement Regarding Elan Law Suits

barbara.lempert Royalty Pharma Deplores What it Believes Are Efforts by Elan to Deprive Shareholders of an Opportunity to Consider Royalty Pharma Offer Elan Withdraws Law Suit in ...

MacroGenics Presents Phase 1 Data at ASCO

barbara.lempert MacroGenics Presents Phase 1 Data at ASCO Showing Signs of Clinical Benefit for Margetuximab in HER2 Expressing Tumors Phase 2 Clinical Trial Underway to Evaluate ...

Leading Multiple Sclerosis Clinicians and Researchers Join Gns Healthcare’s Advisory Board

barbara.lempert Howard Weiner, Maria Pia Sormani, and Philip De Jager to guide company’s Big Data modeling efforts to improve patient outcomes CAMBRIDGE, Mass. – June ...

NIH Begins Recruitment for Long-Term Study of Diabetes Drug Efficacy

barbara.lempert The National Institutes of Health is looking for volunteers to take part in a study to compare the long-term benefits and risks of four widely used diabetes drugs in ...

New Biogen CSO Brings Solid Academic Background

mia.burns By Mia Burns   In late May, Biogen Idec announced that Spyros Artavanis-Tsakonas, Ph.D. as the new chief scientific officer. Previously, Dr. Artavanis-Tsakonas had served ...

Synta surges on positive lung cancer data for ganetespib

John Carroll Shares of Synta climbed more than 10% today after news spread that its drug ganetespib spurred a 32% increase in survival for advanced lung cancer patients. FierceBiotech ...

Bristol-Myers Announces Phase I Data for Nivolumab and Yervoy

mia.burns Bristol-Myers Squibb Announces Phase 1 Results from First Trial Combining Immune Checkpoint Inhibitors, Investigational Agent Nivolumab and Yervoy® (ipilimumab), in Patients ...

Sanofi takes $285M charge after racking up back-to-back PhIII trial failures

John Carroll FierceBiotech News

FDA Issues CRL for Endo’s Aveed

barbara.lempert Endo Pharmaceuticals Provides Regulatory Update On AVEED™ (Testosterone Undecanoate) Injection MALVERN, Pa., May 30, 2013 /PRNewswire/ — Endo Pharmaceuticals ...

Cochlear Americas Receives FDA Approval

barbara.lempert Cochlear Americas Receives FDA Approval for the First and Only Ear Level Accessory for Waterproof Hearing with Cochlear Implants The Aqua Accessory allows recipients ...

FDA oncology chief Pazdur vows to accelerate “breakthrough” drug R&D

John Carroll FierceBiotech News
Page 30 of 34« First...1020...2829303132...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS